Proteome analysis in normal liver, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma-For a novel diagnosis, treatment and protection of hepatocellular carcinoma
Proteome analysis in normal liver, chronic hepatitis, liver cirrhosis and hepatocellular carcinoma-For a novel diagnosis, treatment and protection of hepatocellular carcinoma
批准号:
15590654
负责人:
MASAKI Tsutomu
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
在人类癌症中,细胞周期蛋白、细胞周期蛋白依赖性蛋白依赖性蛋白激酶(CDK)及其抑制物(CDKI)经常发生改变。P18^<;INK4C>;是CDKI中INK4家族的成员,是一种潜在的肿瘤抑制基因产物。然而,p18^<;INK4C>;在肝细胞癌中的表达仍不清楚。本研究的目的是检测p18^<;INK4C>;在包括肝细胞癌在内的多种肝病中的表达,并评价其在肝细胞癌中的临床意义。为此,我们用免疫组织化学方法检测了p18^-lt;INK4C>;在包括51例肝细胞癌在内的各种肝病中的表达,并研究了p18^-lt;INK4C>;表达与视网膜母细胞瘤蛋白(PRB)的磷酸化以及CDK4和CDK6活性水平之间的关系。免疫组织化学分析显示,p18^<;INK4C>;在肝细胞癌尤其是低分化肝细胞癌中表达频繁缺失。与p18^<;INK4C>;-阳性相比,p18^<;INK4C>;表达缺失与预后不良有关。此外,p18^<;INK4C>;阴性的肝细胞癌中CDK4的Kinas活性高于p18^<;INK4C>;阳性的肝癌。然而,CDK6活性水平在两组肝癌中是相似的。在p18^<;INK4C>;阳性的肝癌中,p18^<;INK4C>;主要与CDK4相互作用,而不是与CDK6相互作用。P18^lt;INK4C>;阴性的肝癌中pRb在Ser 780位发生磷酸化的频率高于p18^lt;INK4C>;阳性的肝癌。提示p18^<;INK4C>;表达缺失可能通过上调CDK4活性在肝细胞癌的分化和发展中起作用。
英文摘要
Cyclins, cyclin-dependent kinases (Cdks), and Cdk inhibitors (CdkIs) are frequently altered in human cancer. p 18^<INK4C>, a member of the INK4 family among CdkIs, is a potential tumor suppressor gene product. However, the expression of p 18^<INK4C> in hepatocellular carcinoma (HCC) remains unknown. The aim of this study was to examine the expression of p18^<INK4C> in various liver diseases including HCC and to assess its clinical significance in HCC. To that end, we examined the expression of p 18^<INK4C> by immunohistochemistry in various liver diseases including 51 HCCs, and also studied the relationship among p 18^<INK4C> expression, the phosphorylation of retinoblastoma protein (pRb), and the activity level of Cdk4 and Cdk6. Immunohistochemical analysis revealed the frequent loss of p18^<INK4C> expression in HCC, especially in poorly differentiated HCC. The loss of p18^<INK4C> expression was shown to be associated with a poor prognosis as compared with that associated with p18^<INK4C>-positivity. Further, the kinas activity of Cdk4 was found to be higher in p18^<INK4C>-negative HCCs than in p 18^<INK4C>-positive HCCs. However, the level of Cdk6 activity was similar in the two groups of HCCs. In p18^<INK4C>-positive HCCs, p18^<INK4C> dominantly interacted with Cdk4 rather than with Cdk6. pRb phosphorylated at Ser 780 was detected more frequently in p18^<INK4C>-negative than in p 18^<INK4C>-positive HCCs. These data suggest that the loss of p18^<INK4C> expression may play a role in the differentiation and development of HCC through the upregulation of Cdk4 activity.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Morishita A, Masaki T, Yoshiji H, 14 Others.: "Reduced Expression of Cell Cycle Regulator p18^<INK4C> in Human Hepatocellular Carcinoma."Hepatology. (In press). (2003)
Morishita A、Masaki T、Yoshiji H、14 其他人:“人肝细胞癌中细胞周期调节因子 p18^<INK4C> 的表达降低。”肝病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Cyclins and cyclin-dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis
DOI:
10.1053/jhep.2003.50112
发表时间:
2003-03-01
期刊:
HEPATOLOGY
影响因子:
13.5
作者:
[Masaki, T, Shiratori, Y, Kuriyama, S]
通讯作者:
Kuriyama, S
Enhanced expression of adaptor molecule p46 Shc in nuclei of gastric cancer.
胃癌细胞核中接头分子 p46 Shc 的表达增强。
DOI:
--
发表时间:
2005
期刊:
Int J Oncol 26
影响因子:
--
作者:
[Yukimasa S, Masaki T, Funaki T, 13 others]
通讯作者:
13 others
Expression of myristoylated alanine-rich C kinase substrate(MARCKS)in hepatocellular carcinoma : comparative study of hepatocellular carcinoma versus liver cirrhosis, chronic hepatitis and normal liver.
肉豆蔻酰化富含丙氨酸C激酶底物(MARCKS)在肝细胞癌中的表达:肝细胞癌与肝硬化、慢性肝炎和正常肝脏的比较研究。
DOI:
--
发表时间:
2005
期刊:
Int J Oncol 26
影响因子:
--
作者:
[Masaki T, Tokuda M, Yoshida S, 16 others.]
通讯作者:
16 others.
Identification of p46Shc overexpressed in hepatoccellular nuclei with high proliferative activity : study of regenerating rat liver.
鉴定在具有高增殖活性的肝细胞核中过表达的 p46Shc:再生大鼠肝脏的研究。
DOI:
--
发表时间:
2004
期刊:
Int J Mol Med 13
影响因子:
--
作者:
[Yuji J, Masaki T, Yoshida S, 9 others]
通讯作者:
9 others
共 22 条
MicroRNAs as target molecular in metastatic liver cancer
-
批准号:22590738
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2010
-
负责人:MASAKI Tsutomu
-
依托单位:
Comprehensive analysis of microRNA and functional study of cancer-specific microRNA
-
批准号:19590770
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2007
-
负责人:MASAKI Tsutomu
-
依托单位:
Functional analysis of enhanced adaptor molecule Shc in the nuclei of the hepatocellular carcinoma
-
批准号:17590649
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:MASAKI Tsutomu
-
依托单位:
海外基金